Lv31
388 积分 2024-07-10 加入
SnapShot: Targeted protein degradation
5天前
已完结
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors
24天前
已完结
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
27天前
已完结
Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical development
28天前
已完结
Current advances and development strategies of orally bioavailable PROTACs
28天前
已完结
Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting Ability
1个月前
已完结
Chapter Two - To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
1个月前
已完结
Protein degraders push into novel target space
1个月前
已关闭
新药人体首次剂量设计的技术考虑
1个月前
已完结
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
A Typhoon Center Location Method on Satellite Images Based on Deep Reinforcement Learning
皖公网安备34019202002308
